Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.
Inovio Pharmaceuticals Inc. (INO) shares fell 3.11% to $1.56 on Friday, marking the second consecutive day of losses. This decline occurred despite a strong overall market, with the NASDAQ up 0.81% and the Dow Jones up 0.48%. Inovio's stock is now 47.63% below its 52-week high of $2.98. Compared to competitors, Johnson & Johnson fell 0.66%, Statera Biopharma remained unchanged, and Pfizer rose 0.75%. Trading volume was 1.7 million, surpassing the 50-day average of 1.6 million.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments